| Identification | Back Directory | [Name]
MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI) | [CAS]
73346-79-9 | [Synonyms]
Li-MUP
MG(AI)
Lithium mupirocin
Lithium pseudomonate
Mupirocin lithium CRS
MUPIROCIN LITHIUM SALT
Lithium mupirocin solution
Mupirocin lithium standard
Mupirocin Lithium (1448923)
Mupirocin Lithium(M3806000)
moxonidine impurity standard
Lithium mupirocin Supplement
LITHIUM MUPIROCIN =95.0% (HPLC)
Pseudomonic acid A lithium salt
MUPIROCIN LITHIUM (100 MG)H0C176926UG
MUPIROCIN LITHIUM (100 MG)H0C176926UG/MG(AI)
Mupirocin LithiumQ: What is
Mupirocin Lithium Q: What is the CAS Number of
Mupirocin Lithium Q: What is the storage condition of
Mupirocin Lithium
lithium,9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate
5,9-anhydro-2,3,4,8-tetradeoxy-8-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]-2-oxiranyl]methyl]-3-methyl-L-talo-Non-2-enonic acid 8-carboxyoctyl ester lithium salt
Lithium 9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoate
9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid lithium salt | [EINECS(EC#)]
815-147-3 | [Molecular Formula]
C26H43O9.Li | [MDL Number]
MFCD11977847 | [MOL File]
73346-79-9.mol | [Molecular Weight]
506.558 |
| Chemical Properties | Back Directory | [storage temp. ]
2-8°C | [solubility ]
H2O: soluble10mg/mL, clear, colorless | [form ]
powder | [color ]
colorless or white | [Optical Rotation]
[α]/D -21.0±2.0°, c = 1 in H2O | [Water Solubility ]
Soluble in water at approximately 10mg/ml | [Stability:]
Hygroscopic | [InChIKey]
XFIKMPRBSORKQP-JATHGWPISA-M |
| Hazard Information | Back Directory | [Uses]
Lithium mupirocin as been used to study mupirocin resistance in staphylococcus aureus and in mycoplasma susceptibility studies . | [Uses]
Mupirocin Lithium is a major component of the pseudomonic acid, an antibiotic complex produced by Pseudomonas fluorescens NCIB 10586. Topical antibacterial. |
|
|